Delirium, Dementia, Amnestic, Cognitive Disorders
Welcome,         Profile    Billing    Logout  
 122 Companies   196 Products   196 Products   116 Mechanisms of Action   3 Trials   2338 News 


«12...910111213141516171819...4647»
  • ||||||||||  Enrollment closed, Trial primary completion date:  Effect of NeuroAD on the Cognitive Function of Alzheimer Patients (clinicaltrials.gov) -  Oct 10, 2015   
    P=N/A,  N=150, Active, not recruiting, 
    Recruiting --> Completed | N=10 --> 8 Recruiting --> Active, not recruiting | Trial primary completion date: Sep 2015 --> Jan 2016
  • ||||||||||  Trial completion:  DIF2: A Support Program for Carers of Persons With Dementia (clinicaltrials.gov) -  Oct 8, 2015   
    P=N/A,  N=230, Completed, 
    Trial primary completion date: Apr 2016 --> Apr 2017 Active, not recruiting --> Completed
  • ||||||||||  Enrollment closed, Trial completion date:  fMRI of Vulnerable Brain Regions in Persons at Risk for Alzheimer's Disease (clinicaltrials.gov) -  Oct 6, 2015   
    P=N/A,  N=390, Active, not recruiting, 
    Active, not recruiting --> Completed Enrolling by invitation --> Active, not recruiting | Trial completion date: Jul 2010 --> Jul 2016
  • ||||||||||  Trial completion:  Alzheimer's Disease: Therapeutic Potential of Estrogen (clinicaltrials.gov) -  Oct 4, 2015   
    P2/3,  N=42, Completed, 
    Enrolling by invitation --> Active, not recruiting | Trial completion date: Jul 2010 --> Jul 2016 No longer recruiting --> Completed
  • ||||||||||  encenicline (EVP-6124) / Forum Pharmaceuticals, Mitsubishi Tanabe
    Enrollment change, Trial termination, Trial primary completion date:  Safety Study of MT-4666 in Subjects With Alzheimer's Disease (clinicaltrials.gov) -  Oct 1, 2015   
    P3,  N=117, Terminated, 
    No longer recruiting --> Completed N=200 --> 117 | Recruiting --> Terminated | Trial primary completion date: Jan 2017 --> Oct 2015; This study was terminated due to the benefit-risk balance of MT-4666.
  • ||||||||||  Trial completion, Enrollment change, Trial initiation date, Trial primary completion date, Video:  09-PP-06: Contribution of Actigraphy and Recognition Video in Apathy Assessment of Alzheimer's Disease : Experimental Research (clinicaltrials.gov) -  Oct 1, 2015   
    P=N/A,  N=42, Completed, 
    N=200 --> 117 | Recruiting --> Terminated | Trial primary completion date: Jan 2017 --> Oct 2015; This study was terminated due to the benefit-risk balance of MT-4666. Recruiting --> Completed | N=35 --> 42 | Initiation date: Sep 2010 --> Sep 2011 | Trial primary completion date: Sep 2010 --> Sep 2012
  • ||||||||||  Trial primary completion date:  PET Imaging in Chronic Traumatic Encephalopathy (clinicaltrials.gov) -  Sep 29, 2015   
    P=N/A,  N=40, Recruiting, 
    Trial primary completion date: Jun 2016 --> Oct 2016 Trial primary completion date: Sep 2015 --> Sep 2016
  • ||||||||||  memantine ER / Generic mfg., galantamine extended release / Generic mfg.
    Trial primary completion date:  Galantamine and Memantine Combination for Cognitive Impairments in Schizophrenia (clinicaltrials.gov) -  Sep 28, 2015   
    P2,  N=10, Recruiting, 
    Recruiting --> Completed | Trial primary completion date: Oct 2009 --> Apr 2010 Trial primary completion date: Sep 2015 --> Sep 2017
  • ||||||||||  encenicline (EVP-6124) / Forum Pharmaceuticals, Mitsubishi Tanabe
    Trial completion, Trial primary completion date:  Safety and Efficacy of MT-4666 (clinicaltrials.gov) -  Sep 28, 2015   
    P2,  N=450, Completed, 
    Trial primary completion date: Sep 2015 --> Sep 2017 Active, not recruiting --> Completed | Trial primary completion date: Oct 2015 --> Jun 2015
  • ||||||||||  atomoxetine / Generic mfg.
    Trial completion, Trial primary completion date:  Atomoxetine Treatment for Cognitive Impairment in Parkinson's Disease (ATM-Cog) (clinicaltrials.gov) -  Sep 25, 2015   
    P2,  N=30, Completed, 
    Active, not recruiting --> Completed | Trial primary completion date: Oct 2015 --> Jun 2015 Recruiting --> Completed | Trial primary completion date: May 2015 --> Aug 2014
  • ||||||||||  Trial primary completion date, Metastases:  A Pilot Study of an RCT to Improve Infection Management in Advanced Dementia (clinicaltrials.gov) -  Sep 25, 2015   
    P2,  N=60, Active, not recruiting, 
    Recruiting --> Completed | Trial primary completion date: May 2015 --> Aug 2014 Trial primary completion date: Aug 2015 --> Feb 2016
  • ||||||||||  Trial primary completion date:  Study to Evaluate Coconut Oil for Alzheimer's Disease (clinicaltrials.gov) -  Sep 25, 2015   
    P2/3,  N=65, Recruiting, 
    Trial primary completion date: Aug 2015 --> Feb 2016 Trial primary completion date: Dec 2015 --> Dec 2016
  • ||||||||||  donepezil / Generic mfg.
    Trial primary completion date:  Olfactory Deficits in MCI as Predictor of Improved Cognition on Donepezil (clinicaltrials.gov) -  Sep 25, 2015   
    P4,  N=60, Active, not recruiting, 
    Trial primary completion date: Dec 2015 --> Dec 2016 Trial primary completion date: Apr 2015 --> Mar 2016
  • ||||||||||  S-equol (AUS-131) / Ausio Pharma
    Trial primary completion date:  S-Equol in Alzheimer's Disease (SEAD) Trial (clinicaltrials.gov) -  Sep 24, 2015   
    P1,  N=15, Recruiting, 
    Trial primary completion date: Nov 2016 --> Feb 2016 Trial primary completion date: Jun 2015 --> Dec 2015
  • ||||||||||  donanemab (LY3002813) / Eli Lilly
    Trial primary completion date:  A Study of LY3002813 in Participants With Alzheimer's Disease (clinicaltrials.gov) -  Sep 24, 2015   
    P1,  N=100, Active, not recruiting, 
    Trial primary completion date: Jun 2015 --> Dec 2015 Trial primary completion date: Sep 2015 --> Sep 2016
  • ||||||||||  Trial completion:  Music Therapy in Alzheimer's Disease (clinicaltrials.gov) -  Sep 3, 2015   
    P=N/A,  N=35, Completed, 
    Recruiting --> Active, not recruiting Recruiting --> Completed
  • ||||||||||  Trial completion, Trial primary completion date:  Families Affected by Dementia: A Survey of Caregivers (clinicaltrials.gov) -  Aug 29, 2015   
    P=N/A,  N=60, Completed, 
    Recruiting --> Completed Recruiting --> Completed | Trial primary completion date: Jul 2014 --> Jun 2015